跳至主要内容
临床试验/JPRN-UMIN000010492
JPRN-UMIN000010492已完成未知

Observational study for evaluation of effecacy and safety of ethinylestradiol therapy for postmenopausal hormone receptor-positive metastatic breast cancer patients heavily pre-treated with endocrine treatment - EE2 Observational Study

Study group for metastatic breast cancer0 个研究点目标入组 65 人开始时间: 2013年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. History of deep vain thrombosis, myocardial infarction and brain infarction 2. Active double cancer, history of endometrial cancer and History of other cancer within 5 years (exclued in-situ cervical cancer, basal cell carcinoma and squamous cell carcinoma of the skin) 3. HER2-positive breast cancer 4. Bilateral breast cancer 5. inflamatory breast cancer 6. History of sever drug hypersensitivity 7. pregnant or nursing female 8. life-threatening metastatic breast cancer 9. The case which the family doctor judged to be unsuitable for the object of the study

研究者

发起方
Study group for metastatic breast cancer

相似试验